Monday, November 20, 2017
PharmEvo Worldwide
News

Business Development

International partnerships have always been an important element in PharmEvo’s success and will continue to play a pivotal role in company’s future.

 

We plan to develop our business by Licensing or Acquiring Proprietary / Patented products to market in our part of the world,

 

By building partnerships with overseas companies for products, manufactured by PharmEvo and expanding our presence in new markets.

 

PharmEvo Offers

Established and proven sales and marketing success record in countries where we operate.

An aggressive management team and supportive corporate culture.

Proven product development and regulatory affairs capability.

Flexible and creative approach to collaborations.

The ability to respond quickly to opportunities.

 

In-licensing

We are seeking Proprietary, Patented, Generic Plus, and New Drug Delivery Systems products to market through our established sales, marketing and distribution infrastructure.

 

Our Focused Therapy Areas Are

Anti-Infective, Gastroenterology, Cardiovascular, Endocrinology, CNS, Musculo-Skeletal, Respiratory, Blood & Blood Forming Products, Nutrition, Oncology, Women & Child Health, Probiotics and Biotechnology / Biosimilars.

 

We are already in agreements with some global HealthCare companies from Europe, Americas and Asia.

 

International Presence

As part of our evolving global aims, we are showing our presence in many countries around the world. PharmEvo holds more than 200 marketing authorizations of its products in overseas markets and number is increasing ever since.

 

Focused Overseas Markets

1. South America

2. Central Asia

3. Middle East & Africa

4. Asia Pacific

 

Contact

Nadeem Rehmat

Director Business Development

Email: nadeem.rehmat@pharmevo.biz

Phone: +92-21-34315195-7